Benchmarking: Applications to Transfusion Medicine

Transfusion Medicine Reviews

Volumn 26, Issue 4, 2012, Pages 321-332

  Apelseth, Torunn Oveland ^a   Molnar, Laura ^b   Arnold, Emmy ^c   Heddle, Nancy M ^d  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c MCMASTER UNIVERSITY   (Canada)

^d CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; COST EFFECTIVENESS ANALYSIS; ELECTRONICS; HUMAN; INFORMATION PROCESSING; MEDICAL LITERATURE; PUBLICATION; QUALITY CONTROL; SAFETY; SENTINEL EVENT; SYSTEMATIC REVIEW;

BENCHMARKING; BLOOD SAFETY; BLOOD TRANSFUSION; EVIDENCE-BASED MEDICINE; HOSPITALS; HUMANS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84866446121     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2011.12.003     Document Type: Article

References (55)

1. Friedman B.A., Burns T.L., Schork M.A. A study of blood utilization by diagnosis, month of transfusion, and geographic region of the United States. Transfusion 1979, 19:511-525.
2. Vichi M. Benchmarking in the transfusion sector. Blood Transfus 2006, 4:1-11.
3. Kearns D.T. Leadership through quality. Academy of Management Executive 1990, Vol.4. No. 2: 86-9 Issue Stable URL. http://www.jstor.org/stable/i395805.
4. Camp R. Benchmarking: the search for industry best practices that lead to superior performance 1989, American Society for Quality Control Quality Press, Wisconsin.
5. PubMed.). http://www.nlm.nih.gov/mesh/meshhome.html.
6. Palo R., Capraro L., Hovilehto S., Koivuranta M., Krusius T., Loponen, et al. Population-based audit of fresh-frozen plasma transfusion practices. Transfusion 2006, 46:1921-1925.
7. Zarbo R.J., Jones B.A., Friedberg R.C., Valenstein P.N., Renner S.W., Schifman R.B., et al. Q-tracks: a College of American Pathologists program of continuous laboratory monitoring and longitudinal tracking. Arch Pathol Lab Med 2002, 126:1036-1044.
8. Schramm W., Berger K. Influencing blood usage in Germany: what is optimal use?. Transfusion 2007, 47:152S-154S. [discussion 155S-156S].
9. Chetcuti S.J., Grossman P.M., Kline-Rogers E.M., Montoye C., Smith D., Moscucci M. Improving outcomes of percutaneous coronary intervention through the application of guidelines and benchmarking: reduction of major bleeding and blood transfusion as a model. Clin Cardiol 2007, 30:II44-48.
10. Blanchette C.M., Wang P.F., Joshi A.V., Kruse P., Asmussen M., Saunders W. Resource utilization and costs of blood management services associated with knee and hip surgeries in US hospitals. Adv Ther 2006, 23:54-67.
11. Maki T. Optimizing blood usage through benchmarking. Transfusion 2007, 47:145S-148S. [discussion 155S-156S].
12. Callum J.L., Merkley L.L., Coovadia A.S., Lima A.P., Kaplan H.S. Experience with the medical event reporting system for transfusion medicine (MERS-TM) at three hospitals. Transfus Apher Sci 2004, 31:133-143.
13. Beckman N., Nicholson G., Ashford M., Hambleton R. Blood pack fault monitoring. Vox Sang 2004, 87:272-279.
14. Chapman J.F., Cook R. The Blood Stocks Management Scheme, a partnership venture between the National Blood Service of England and North Wales and participating hospitals for maximizing blood supply chain management. Vox Sang 2002, 83:239-246.
15. Heddle N.M., Liu Y., Barty R., Webert K.E., Whittaker S., Gagliardi K., et al. Factors affecting the frequency of red blood cell outdates: an approach to establish benchmarking targets. Transfusion 2009, 49:219-226.
16. Freedman J., Luke K., Escobar M., Vernich L., Chiavetta J.A. Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). Transfusion 2008, 48:237-250.
17. McClelland B. Clinical quality improvement information for transfusion practice. Transfusion 2007, 47:137S-141S. [discussion 155S-156S].
18. Surgenor D.M., Wallace E.L., Hale S.G., Gilpatrick M.W. Changing patterns of blood transfusions in four sets of United States hospitals, 1980 to 1985. Transfusion 1988, 28:513-518.
19. Gombotz H., Rehak P.H., Shander A., Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007, 47:1468-1480.
20. Capraro L., Nuutinen L., Myllyla G. Transfusion thresholds in common elective surgical procedures in Finland. Vox Sang 2000, 78:96-100.
21. Blanchette C.M., Joshi A.V., Szpalski M., Gunzburg R., Du Bois M., Donceel P., et al. Comparison between spinal surgery blood transfusion services costs and associated treatment practices in the United States and Belgium. Curr Med Res Opin 2007, 23:2793-2804.
22. Covin R., O'Brien M., Grunwald G., Brimhall B., Sethi G., Walczak S., et al. Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery. Arch Pathol Lab Med 2003, 127:415-423.
23. Karkouti K., Wijeysundera D.N., Beattie W.S., Callum J.L., Cheng D., Dupuis J.Y., et al. Variability and predictability of large-volume red blood cell transfusion in cardiac surgery: a multicenter study. Transfusion 2007, 47:2081-2088.
24. Andreasen J.J., Westen M., Pallesen P.A., Jensen S., Gorst-Rasmussen A., Johnsen S.P. Transfusion practice in coronary artery bypass surgery in Denmark: a multicenter audit. Interact Cardiovasc Thorac Surg 2007, 6:623-627.
25. Goodnough L.T., Johnston M.F., Toy P.T. The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group. JAMA 1991, 265:86-90.
26. Surgenor D.M., Wallace E.L., Churchill W.H., Hao S.H., Chapman R.H., Collins J.J. Red cell transfusions in coronary artery bypass surgery (DRGs 106 and 107). Transfusion 1992, 32:458-464.
27. Surgenor D.M., Churchill W.H., Wallace E.L., Rizzo R.J., McGurk S., Goodnough L.T., et al. The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals. Transfusion 1998, 38:122-134.
28. Corwin H.L., Gettinger A., Pearl R.G., Fink M.P., Levy M.M., Abraham E., et al. The CRIT study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004, 32:39-52.
29. Hebert P.C., Wells G., Martin C., Tweeddale M., Marshall J., Blajchman M., et al. Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study. Crit Care 1999, 3:57-63.
30. Ozier Y., Pessione F., Samain E., Courtois F. Institutional variability in transfusion practice for liver transplantation. Anesth Analg 2003, 97:671-679.
31. Hutton B., Fergusson D., Tinmouth A., McIntyre L., Kmetic A., Hebert P.C. Transfusion rates vary significantly amongst Canadian medical centres. Can J Anaesth 2005, 52:581-590.
32. Use of blood products for elective surgery in 43 European hospitals. Transfus Med 1994, 4:251-268. The Sanguis Study Group.
33. Churchill W.H., McGurk S., Chapman R.H., Wallace E.L., Bertholf M.F., Goodnough L.T., et al. The Collaborative Hospital Transfusion Study: variations in use of autologous blood account for hospital differences in red cell use during primary hip and knee surgery. Transfusion 1998, 38:530-539.
34. Audet A.M., Andrzejewski C., Popovsky M.A. Red blood cell transfusion practices in patients undergoing orthopedic surgery: a multi-institutional analysis. Orthopedics 1998, 21:851-858.
35. Cook S.S., Cangialose C.B., Sieburg D.M., Kieszak S.M., Boudreau R., Hoffman L.H., et al. Red blood cell transfusions for elective hip and knee arthroplasty: opportunity to improve quality of care and documentation. Clin Perform Qual Health Care 1999, 7:5-16.
36. Sekimoto M., Imanaka Y., Shirai T., Sasaki H., Komeno T., Lee J., Yoshihara K., et al. Risk-adjusted assessment of incidence and quantity of blood use in acute-care hospitals in Japan: an analysis using administrative data. Vox Sang 2009, 98:538-546.
37. Borkent-Raven B.A., Janssen M., van der Poel C.L., Schaasberg W.P., Bonsel G.J., van Hout B.A. The PROTON study: profiles of blood product transfusion recipients in the Netherlands. Vox Sang 2010, 99:54-64.
38. Surgenor D.M., Wallace E.L., Churchill W.H., Hao S.H., Chapman R.H., Poss R. Red cell transfusions in total knee and total hip replacement surgery. Transfusion 1991, 31:531-537.
39. Slonim A.D., Joseph J.G., Turenne W.M., Sharangpani A., Luban N.L. Blood transfusions in children: a multi-institutional analysis of practices and complications. Transfusion 2008, 48:73-80.
40. Lundy D., Laspina S., Kaplan H., Rabin Fastman B., Lawlor E. Seven hundred and fifty-nine (759) chances to learn: a 3-year pilot project to analyse transfusion-related near-miss events in the Republic of Ireland. Vox Sang 2007, 92:233-241.
41. Lam H.C., Kominski G.F., Petz L.D., Sofaer S. Factors affecting the labor efficiency of hospital-based blood bank laboratories. Transfusion 1994, 34:811-817.
42. Novis D.A., Renner S., Friedberg R., Walsh M.K., Saladino A.J. Quality indicators of blood utilization: three College of American Pathologists Q-Probes studies of 12,288,404 red blood cell units in 1639 hospitals. Arch Pathol Lab Med 2002, 126:150-156.
43. Capraro L. Transfusion practices in primary total joint replacements in Finland. Vox Sang 1998, 75:1-6.
44. Palo R., Ali-Melkkila T., Hanhela R., Jantti V., Krusius T., Leppanen E., et al. Development of permanent national register of blood component use utilizing electronic hospital information systems. Vox Sang 2006, 91:140-147.
45. Goodnough L.T., Soegiarso R.W., Birkmeyer J.D., Welch H.G. Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. Am J Med 1993, 94:509-514.
46. Titlestad K., Georgsen J., Jorgensen J., Kristensen T. Monitoring transfusion practices at two university hospitals. Vox Sang 2001, 80:40-47.
47. Chiavetta J.A., Herst R., Freedman J., Axcell T.J., Wall A.J., van Rooy S.C. A survey of red cell use in 45 hospitals in central Ontario, Canada. Transfusion 1996, 36:699-706.
48. Thomson A., Contreras M., Knowles S. Blood component treatment: a retrospective audit in five major London hospitals. J Clin Pathol 1991, 44:734-737.
49. Schofield W.N., Rubin G.L., Dean M.G. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med J Aust 2003, 178:117-121.
50. Pinkerton P.H. Transfusion practice in a Canadian hospital. Use of a major European study of trasfusion practice for comparison as a form of audit. Transfus Sci 1996, 17:303-308.
51. So-Osman C., Cicilia J., Brand A., Schipperus M., Berning B., Scherjon E.S. Triggers and appropriateness of red blood cell transfusions in the postpartum patient-a retrospective audit. Vox Sang 2010, 98:65-69.
52. Murphy M.F., Stearn B.E., Dzik W.H. Current performance of patient sample collection in the UK. Transfus Med 2004, 14:113-121.
53. Dzik W.H., Murphy M.F., Andreu G., Heddle N., Hogman C., Kekomaki R., et al. An international study of the performance of sample collection from patients. Vox Sang 2003, 85:40-47.
54. Gorham M. Blood center and hospital partnerships that increase transfusion safety and value: a European perspective. Transfusion 2007, 47:106S-108S. [discussion 117S-119S].
55. Beckman N., Sher G., Masse M., Richter E., Ringwald J., Rebulla P., et al. Review of the quality monitoring methods used by countries using or implementing universal leukoreduction. Transfus Med Rev 2004, 18:25-35.